Epratuzumab (CD22) Antibody, Monoclonal
| Code | Size | Price |
|---|
| PSI-10-073-0.1mg | 0.1mg | £657.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Antibody Isotype: IgG1-nd
Antibody Clonality: Recombinant Antibody
Regulatory Status: RUO
Shipping:
blue ice
Storage:
Store at -80˚C
Documents
Further Information
Additional Names:
90Y-DOTA-hLL2,90Y-epratuzumab tetraxetan,AMG-412,90Y-hLL2,hLL2, CD22, CD22
Background:
Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody,LL2 (EPB-2).This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders,such as lupus.
Buffer:
PBS buffer pH7.5
Concentration:
batch dependent
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
Humanized / CD22 [Homo sapiens]
NCBI Organism:
homo sapiens
Purification:
>95%
Research Area:
Drug Analogues
Source:
CHO cells
Swissprot #:
P20273
User NOte:
Optimal dilutions for each application to be determined by the researcher.